289 related articles for article (PubMed ID: 18340251)
21. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
Sato H; Enmi J; Teramoto N; Hayashi T; Yamamoto A; Tsuji T; Naito H; Iida H
Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
[TBL] [Abstract][Full Text] [Related]
22. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
23. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Giovagnoni A; Paci E
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation.
Pastor CM; Planchamp C; Pochon S; Lorusso V; Montet X; Mayer J; Terrier F; Vallee JP
Radiology; 2003 Oct; 229(1):119-25. PubMed ID: 12944603
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
Pavone P; Patrizio G; Buoni C; Tettamanti E; Passariello R; Musu C; Tirone P; Felder E
Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112
[TBL] [Abstract][Full Text] [Related]
26. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
Kuhn MJ; Picozzi P; Maldjian JA; Schmalfuss IM; Maravilla KR; Bowen BC; Wippold FJ; Runge VM; Knopp MV; Wolansky LJ; Gustafsson L; Essig M; Anzalone N
J Neurosurg; 2007 Apr; 106(4):557-66. PubMed ID: 17432704
[TBL] [Abstract][Full Text] [Related]
28. MR imaging of CNS tumors: are all contrast agents created the same?
Essig M
Neuroradiology; 2006 Apr; 48 Suppl 1():3-8. PubMed ID: 16699847
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Gd-Bz-TTDA, Gd-EOB-DTPA, and Gd-BOPTA for dynamic MR imaging of the liver in rat models.
Jaw TS; Chen SH; Wang YM; Hsu JS; Kuo YT; Chiu YY; Tsai KB; Hsieh TJ; Liu GC
Kaohsiung J Med Sci; 2012 Mar; 28(3):130-7. PubMed ID: 22385605
[TBL] [Abstract][Full Text] [Related]
30. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
[TBL] [Abstract][Full Text] [Related]
31. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent: early phase II study in brain tumors and dual dynamic contrast-enhanced imaging.
Ito M; Ogino H; Oshima H; Shiraki N; Shibamoto Y; Kasai H; Mase M; Kawamura Y; Miyati T
Magn Reson Imaging; 2006 Jun; 24(5):625-30. PubMed ID: 16735185
[TBL] [Abstract][Full Text] [Related]
33. [Multiphasic MR angiography as an intra-individual comparison between the contrast agents Gd-DTPA, Gd-BOPTA, and Gd-BT-DO3A].
von Tengg-Kobligk H; Floemer F; Knopp MV
Radiologe; 2003 Feb; 43(2):171-8. PubMed ID: 12624674
[TBL] [Abstract][Full Text] [Related]
34. In vivo gadolinium neutron capture therapy using a potentially effective compound (Gd-BOPTA).
Matsumura A; Zhang T; Yamamoto T; Yoshida F; Sakurai Y; Shimojo N; Nose T
Anticancer Res; 2003; 23(3B):2451-6. PubMed ID: 12894527
[TBL] [Abstract][Full Text] [Related]
35. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla.
Klumpp B; Fenchel M; Hoevelborn T; Helber U; Scheule A; Claussen C; Miller S
Invest Radiol; 2006 Sep; 41(9):661-7. PubMed ID: 16896300
[TBL] [Abstract][Full Text] [Related]
36. [Enhanced MR-angiography (CE-MRA) of the supraaortic arteries: dose reduction with a contrast agent of high relaxivity (Gd-BOPTA)].
Friese S; Klose U; Kastrup A; Krapf H; Küker W
Rofo; 2003 Oct; 175(10):1363-7. PubMed ID: 14556105
[TBL] [Abstract][Full Text] [Related]
37. [Gd-DTPA in the diagnosis of brain metastasis].
Kornienko VN; Pronin IN
Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209
[TBL] [Abstract][Full Text] [Related]
38. 3.0 Tesla high spatial resolution contrast-enhanced magnetic resonance angiography (CE-MRA) of the pulmonary circulation: initial experience with a 32-channel phased array coil using a high relaxivity contrast agent.
Nael K; Fenchel M; Krishnam M; Finn JP; Laub G; Ruehm SG
Invest Radiol; 2007 Jun; 42(6):392-8. PubMed ID: 17507810
[TBL] [Abstract][Full Text] [Related]
39. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis.
Akpinar E; Turkbey B; Karcaaltincaba M; Balli O; Akkapulu N; Balas S; Tirnaksiz B; Akata D; Akhan O
J Magn Reson Imaging; 2009 Sep; 30(3):578-85. PubMed ID: 19711404
[TBL] [Abstract][Full Text] [Related]
40. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)].
Fang YX
Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):305-7, 22. PubMed ID: 2804747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
